Larry Mathis Financial Planning’s AbbVie ABBV Stock Holding History

Larry Mathis Financial Planning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.43B	Buy	+5,695	New	+$1.23M	1.15%	15

Other funds holding ABBV

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Larry Mathis Financial Planning's ABBV Position: Q2 2026 in Review

Larry Mathis Financial Planning opened a new position in AbbVie (ABBV) in Q2 2026: 5,695 shares worth $1.43B. The stake represents 1.15% of the portfolio and ranks #15 among its holdings.

803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Larry Mathis Financial Planning held 5,695 shares of AbbVie worth $1.43B as of Q2 2026.
AbbVie was a new Larry Mathis Financial Planning position in Q2 2026.
AbbVie made up 1.15% of Larry Mathis Financial Planning's portfolio in Q2 2026, its #15 holding.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Larry Mathis Financial Planning's 13F filing for Q2 2026, filed 17 Jul 2026.